The total fluoride concentration in unstimulated whole saliva was measured before and at selected intervals after a self-applied 1.1% neutral NaF topical fluoride gel or use of a 0.05% neutral NaF fluoride mouthrinse in both normal individuals and patients with radiation-induced xerostomia. As expected, the gel resulted in higher peak fluoride values than the rinse and was retained in the mouth for longer periods of time in both groups. The xerostomic group expressed a mean oral fluoride concentration of 575 μg fluoride per gram of saliva within 1 min after the gel application and 150 μg/g following use of the mouthrinse, whereas the normal group exhibited peak concentrations of 112 and 71 μg/g, respectively, within 1 min after the same two treatments. The initial high levels of fluoride observed in normal subjects following the gel application decreased rapidly to less than 1 μg/g within 2 h, whereas fluoride levels in the xerostomic subjects remained elevated above 12 μg/g for longer than 2 h. Similarly, following use of the mouthrinse, normal subjects’ saliva fluoride levels decreased to less than 1 μg/g within 1 h, whereas xerostomic subjects’ saliva fluoride levels remained above 4 μg/g for longer than 2 h.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.